Merck discontinues Recarbio in the US despite concerns over superbug resistance
STAT describes Recarbio as an important antibiotic in the US and reports that Merck discontinued it despite concerns over resistance to superbugs.
TLDR
STAT reports that Merck discontinued Recarbio in the US. The outlet describes it as an important antibiotic and says the decision came despite concerns over resistance to superbugs.
Combined views
1.6K
1 Source, first seen 4h ago
1 likes